9/8/2024, 10:09:02 am

JB Pharma stock surges to 52-week high on stellar Q1 earnings show

Shares of JB Chemicals & Pharmaceuticals surged 3% to a 52-week high after the company reported strong earnings for Q1 FY25, with revenue crossing Rs 1000 crore for the first time, driven by 22% growth in domestic formulations sales, and a 25% increase in net profit, with operating margins expected to stay in the range of 26-28%.